1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 SER 32 - ASP 33 MODEL 1 OMEGA =218.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION SER 32 - ASP 33 MODEL 10 OMEGA =215.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION SER 32 - ASP 33 MODEL 15 OMEGA =219.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION Szyperski, T. Guntert, P. Stone, S.R. Wuthrich, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 228 1193 1205 10.1016/0022-2836(92)90325-E 1335515 Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain. 1992 UK J.Mol.Biol. JMOBAK 0070 0022-2836 228 1206 Impact of Protein-Protein Contacts on the Conformation of Thrombin-Bound Hirudin Studied by Comparison with the NMR Solution Structure of Hirudin(1-51) 1992 US Biochemistry BICHAW 0033 0006-2960 28 4301 Conformation of Recombinant Desulfatohirudin in Aqueous Solution Determined by Nuclear Magnetic Resonance 1989 US Biochemistry BICHAW 0033 0006-2960 28 2601 Solution Structure of Recombinant Hirudin and the Lys 47-Glu Mutant: A Nuclear Magnetic Resonance and Hybrid Geometry-Dynamical Simulated Annealing Study 1989 10.2210/pdb1hic/pdb pdb_00001hic 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5293.813 HIRUDIN VARIANT 1 man polymer no no VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSH VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n medicinal leech Hirudo sample 6421 Hirudo medicinalis database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name Y BNL 1992-04-30 REL REL 20 GUNTERT,BRAUN,WUTHRICH refinement DIANA SINGH,WEINER,CALDWELL,KOLLMAN refinement Amber 3.0 VAL 1 n 1 VAL 1 A VAL 2 n 2 VAL 2 A TYR 3 n 3 TYR 3 A THR 4 n 4 THR 4 A ASP 5 n 5 ASP 5 A CYS 6 n 6 CYS 6 A THR 7 n 7 THR 7 A GLU 8 n 8 GLU 8 A SER 9 n 9 SER 9 A GLY 10 n 10 GLY 10 A GLN 11 n 11 GLN 11 A ASN 12 n 12 ASN 12 A LEU 13 n 13 LEU 13 A CYS 14 n 14 CYS 14 A LEU 15 n 15 LEU 15 A CYS 16 n 16 CYS 16 A GLU 17 n 17 GLU 17 A GLY 18 n 18 GLY 18 A SER 19 n 19 SER 19 A ASN 20 n 20 ASN 20 A VAL 21 n 21 VAL 21 A CYS 22 n 22 CYS 22 A GLY 23 n 23 GLY 23 A GLN 24 n 24 GLN 24 A GLY 25 n 25 GLY 25 A ASN 26 n 26 ASN 26 A LYS 27 n 27 LYS 27 A CYS 28 n 28 CYS 28 A ILE 29 n 29 ILE 29 A LEU 30 n 30 LEU 30 A GLY 31 n 31 GLY 31 A SER 32 n 32 SER 32 A ASP 33 n 33 ASP 33 A GLY 34 n 34 GLY 34 A GLU 35 n 35 GLU 35 A LYS 36 n 36 LYS 36 A ASN 37 n 37 ASN 37 A GLN 38 n 38 GLN 38 A CYS 39 n 39 CYS 39 A VAL 40 n 40 VAL 40 A THR 41 n 41 THR 41 A GLY 42 n 42 GLY 42 A GLU 43 n 43 GLU 43 A GLY 44 n 44 GLY 44 A THR 45 n 45 THR 45 A PRO 46 n 46 PRO 46 A LYS 47 n 47 LYS 47 A PRO 48 n 48 PRO 48 A GLN 49 n 49 GLN 49 A SER 50 n 50 SER 50 A HIS 51 n 51 HIS 51 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 14 A N CYS 14 A O CYS 22 A O CYS 22 A O ILE 29 A O ILE 29 A N GLN 38 A N GLN 38 1 A A SER ASP 32 33 -141.51 10 A A SER ASP 32 33 -144.17 15 A A SER ASP 32 33 -140.14 7 A TYR 3 0.067 SIDE CHAIN 11 A TYR 3 0.070 SIDE CHAIN 17 A TYR 3 0.079 SIDE CHAIN 19 A TYR 3 0.072 SIDE CHAIN 2 7.52 1.10 114.20 121.72 A A A CA CB SG CYS CYS CYS 14 14 14 N 4 8.43 1.10 114.20 122.63 A A A CA CB SG CYS CYS CYS 14 14 14 N 9 7.29 1.10 114.20 121.49 A A A CA CB SG CYS CYS CYS 6 6 6 N 9 7.01 1.10 114.20 121.21 A A A CA CB SG CYS CYS CYS 14 14 14 N 10 7.08 1.10 114.20 121.28 A A A CA CB SG CYS CYS CYS 14 14 14 N 11 6.83 1.10 114.20 121.03 A A A CA CB SG CYS CYS CYS 14 14 14 N 17 7.24 1.10 114.20 121.44 A A A CA CB SG CYS CYS CYS 14 14 14 N 20 7.58 1.10 114.20 121.78 A A A CA CB SG CYS CYS CYS 14 14 14 N 1 A CYS 16 -143.14 -63.06 1 A ASP 33 153.09 34.87 1 A SER 50 61.19 144.58 3 A GLU 8 -176.12 145.80 3 A CYS 16 -109.94 -63.72 3 A SER 32 -101.35 69.96 3 A GLN 49 -48.87 158.04 3 A SER 50 -150.28 67.11 4 A CYS 16 -95.23 -64.43 4 A SER 32 -144.34 43.22 4 A ASP 33 170.27 37.04 4 A GLU 43 -170.21 147.35 4 A SER 50 65.45 168.80 5 A SER 50 67.23 91.16 6 A CYS 16 -131.14 -63.76 6 A SER 50 -101.33 -60.72 7 A CYS 16 -142.07 -64.15 7 A ASP 33 95.75 73.44 8 A SER 32 -157.45 72.31 9 A CYS 16 -131.90 -68.40 9 A GLU 43 68.49 144.95 9 A SER 50 74.09 151.56 10 A CYS 16 -106.94 -63.36 10 A SER 32 -143.67 42.09 10 A ASP 33 160.09 28.38 10 A GLU 43 42.11 83.75 11 A THR 7 -134.45 -39.21 11 A LEU 13 71.38 38.50 11 A CYS 16 -120.69 -63.98 11 A SER 32 -101.83 67.67 12 A CYS 16 -127.66 -62.93 13 A LEU 13 74.73 53.36 13 A CYS 16 -139.21 -63.24 13 A ASP 33 38.74 67.39 13 A GLU 43 58.50 144.90 13 A GLN 49 -44.24 151.53 14 A CYS 16 -107.32 -63.17 14 A LEU 30 -69.73 73.91 14 A ASP 33 49.63 28.02 14 A SER 50 67.48 -75.64 15 A CYS 16 -127.64 -63.64 15 A ASP 33 152.89 28.42 15 A GLU 43 72.06 83.51 15 A SER 50 -172.93 -64.77 16 A CYS 16 -138.89 -63.20 16 A SER 32 -176.38 94.61 16 A GLU 43 73.68 154.97 16 A SER 50 63.64 162.15 17 A LEU 15 -57.68 108.88 17 A CYS 16 -99.18 -63.15 17 A ASP 33 164.07 49.72 17 A LYS 47 -50.77 108.23 18 A THR 7 -141.35 28.00 18 A CYS 16 -142.31 -64.57 18 A ASP 33 78.05 61.76 18 A SER 50 67.86 174.46 19 A CYS 16 -123.07 -63.43 19 A ASP 33 87.38 61.49 20 A CYS 16 -140.84 -63.94 20 A SER 50 -163.58 -41.57 THE NMR SOLUTION STRUCTURE OF HIRUDIN(1-51) AND COMPARISON WITH CORRESPONDING THREE-DIMENSIONAL STRUCTURES DETERMINED USING THE COMPLETE 65-RESIDUE HIRUDIN POLYPEPTIDE CHAIN 1 Y N disulf 2.067 A CYS 6 A SG CYS 6 1_555 A CYS 14 A SG CYS 14 1_555 disulf 2.162 A CYS 16 A SG CYS 16 1_555 A CYS 28 A SG CYS 28 1_555 disulf 2.088 A CYS 22 A SG CYS 22 1_555 A CYS 39 A SG CYS 39 1_555 HIRUDIN HIRUDIN ITH1_HIRME UNP 1 1 P01050 VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ 1 51 1HIC 1 51 P01050 A 1 1 51 2 2 anti-parallel anti-parallel A CYS 14 A CYS 14 A CYS 16 A CYS 16 A ASN 20 A ASN 20 A CYS 22 A CYS 22 A LYS 27 A LYS 27 A GLY 31 A GLY 31 A LYS 36 A LYS 36 A VAL 40 A VAL 40 1 P 1